Ma, J., & Waxman, D. J. (2009). Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib.
Chicago-стиль цитированияMa, Jie, and David J. Waxman. Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib. 2009.
MLA-цитированиеMa, Jie, and David J. Waxman. Dominant Effect of Anti-angiogenesis in Combination Therapy Involving Cyclophosphamide and the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib. 2009.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.